Holen Sie sich die Stockscreener-App
1.24
2.73%
-0.04
Handel nachbörslich:
1.27
0.03
+2.42%
Schlusskurs vom Vortag:
$1.28
Offen:
$1.25
24-Stunden-Volumen:
456.41K
Relative Volume:
0.06
Marktkapitalisierung:
$73.78M
Einnahmen:
$45.91M
Nettoeinkommen (Verlust:
$-4.62M
KGV:
-8.8445
EPS:
-0.1402
Netto-Cashflow:
$-21.51M
1W Leistung:
-16.44%
1M Leistung:
-33.42%
6M Leistung:
+156.01%
1J Leistung:
+43.00%
1-Tages-Spanne:
$1.21
$1.29
1-Wochen-Bereich:
$1.21
$1.49
52-Wochen-Spanne:
$0.27
$2.35
Equillium Inc Stock (EQ) Company Profile
Firmenname
Equillium Inc
Sektor
Branche
Telefon
(858) 412-5302
Adresse
2223 AVENIDA DE LA PLAYA, LA JOLLA, CA
Vergleichen Sie EQ mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EQ
Equillium Inc
|
1.24 | 76.16M | 45.91M | -4.62M | -21.51M | -0.1402 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Equillium Inc Stock (EQ) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-28 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2021-10-29 | Fortgesetzt | Stifel | Buy |
| 2021-09-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-07-14 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-10 | Fortgesetzt | Stifel | Buy |
| 2019-02-22 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Equillium Inc Aktie (EQ) Neueste Nachrichten
Is Equillium Inc. building a consolidation baseWeekly Risk Report & Reliable Intraday Trade Alerts - newser.com
How cyclical is Equillium Inc. (0FY) stock compared to rivalsTrade Entry Summary & Fast Gaining Stock Strategy Reports - newser.com
Is Equillium Inc. showing signs of accumulationWeekly Profit Report & Long-Term Growth Portfolio Plans - newser.com
Will Equillium Inc. stock continue upward momentumQuarterly Trade Review & Accurate Trade Setup Notifications - newser.com
Intraday pattern recognizer results for Equillium Inc.Day Trade & Low Risk Investment Opportunities - newser.com
What to expect from Equillium Inc. in the next 30 daysMarket Movers & Verified Technical Signals - newser.com
Is it too late to sell Equillium Inc.Insider Buying & AI Enhanced Trading Signals - newser.com
Will Equillium Inc. rebound enough to break evenShare Buyback & Fast Gain Stock Tips - newser.com
Real time scanner hits for Equillium Inc. explained2025 EndofYear Setup & Intraday High Probability Alerts - newser.com
Is it time to cut losses on Equillium Inc.Weekly Trend Report & Entry Point Strategy Guides - newser.com
Will Equillium Inc. price bounce be sustainableMarket Trend Report & Weekly Market Pulse Alerts - newser.com
How to manage a losing position in Equillium Inc.July 2025 Action & Daily Growth Stock Investment Tips - newser.com
Why global investors buy Equillium Inc. (0FY) stockEarnings Overview Summary & Weekly Breakout Stock Alerts - newser.com
Will Equillium Inc. (0FY) stock keep high P E multiplesTrade Signal Summary & Daily Profit Maximizing Tips - newser.com
Weiss Ratings Reiterates Sell (E+) Rating for Equillium (NASDAQ:EQ) - Defense World
BRIEF-Equillium Announces Leadership And Corporate Updates - The Sunday Guardian
Equillium announces leadership changes as it shifts focus to EQ504 - Investing.com
Equillium announces leadership changes as it shifts focus to EQ504 By Investing.com - Investing.com Nigeria
Equillium (EQ) Ends Collaboration with Biocon on Itolizumab - GuruFocus
Equillium, Inc. Announces Leadership Changes and Focus on Advancing EQ504 for Inflammatory Diseases - Quiver Quantitative
Equillium, Inc. Announces Management Changes , Effective October 1, 2025 - MarketScreener
What MACD and RSI say about Equillium Inc.July 2025 Decliners & AI Optimized Trading Strategy Guides - newser.com
Why Equillium Inc. (0FY) stock stays undervalued2025 Risk Factors & Safe Swing Trade Setup Alerts - newser.com
Will a bounce in Equillium Inc. offer an exitTrade Entry Report & Expert Approved Trade Ideas - newser.com
What momentum shifts mean for Equillium Inc.Weekly Gains Summary & Technical Analysis for Trade Confirmation - newser.com
Is Equillium Inc. stock bottoming outWeekly Profit Report & AI Forecast Swing Trade Picks - newser.com
Detecting price anomalies in Equillium Inc. with AIMarket Activity Report & AI Forecast for Swing Trade Picks - newser.com
Using RSI to spot recovery in Equillium Inc.July 2025 Setups & Low Risk Profit Maximizing Plans - newser.com
What drives Equillium Inc 0FY stock pricePortfolio Risk Assessment & Low Cost Market Strategies - earlytimes.in
Finanzdaten der Equillium Inc-Aktie (EQ)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):